There's one question I have asked before, and was just getting to before we had to change the order of the questioning: what's being left off the table when we look at research funding? I've asked this of all the different groups that have been before us.
One complaint we've heard in general is that we only really get to 20% of the excellent research, and there just isn't investment available for 80% of the research we'd like to do as a country. Is that something you find specifically in Alzheimer's research as well? We've certainly heard that with MS, Parkinson's, and ALS. Are there any examples of exciting research that we haven't been able to undertake in an interesting field related to Alzheimer's because there just wasn't available room within the CIHR, despite it being an excellent research project?